- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ApoE4: an emerging therapeutic target for Alzheimer’s disease ; volume:17 ; number:1 ; day:20 ; month:3 ; year:2019 ; pages:1-17 ; date:12.2019
BMC medicine ; 17, Heft 1 (20.3.2019), 1-17, 12.2019
- Creator
-
Safieh, Mirna
Korczyn, Amos D.
Michaelson, Daniel M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-019-1299-4
- URN
-
urn:nbn:de:101:1-2019040721383439558167
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Safieh, Mirna
- Korczyn, Amos D.
- Michaelson, Daniel M.
- SpringerLink (Online service)
Other Objects (12)
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rho GTPases as therapeutic targets in Alzheimer’s disease
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rho GTPases as therapeutic targets in Alzheimer’s disease
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rho GTPases as therapeutic targets in Alzheimer’s disease
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease